 Douglas Osborne
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 5 | 2023 | 340 | 1.480 |
Why?
| | Microfilament Proteins | 5 | 2022 | 127 | 0.920 |
Why?
| | Receptors, Antigen, T-Cell | 5 | 2019 | 631 | 0.860 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 170 | 0.780 |
Why?
| | Melanoma | 3 | 2023 | 649 | 0.660 |
Why?
| | Interleukin-1 | 2 | 2022 | 971 | 0.640 |
Why?
| | Histocompatibility Antigens Class II | 3 | 2019 | 352 | 0.630 |
Why?
| | Receptor, IGF Type 2 | 1 | 2015 | 7 | 0.520 |
Why?
| | Integrin alpha5beta1 | 1 | 2015 | 9 | 0.510 |
Why?
| | Sorting Nexins | 1 | 2015 | 10 | 0.510 |
Why?
| | Integrins | 1 | 2015 | 79 | 0.480 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 383 | 0.420 |
Why?
| | Lymphocyte Activation | 2 | 2015 | 1056 | 0.400 |
Why?
| | Antigen Presentation | 1 | 2012 | 189 | 0.390 |
Why?
| | MAP Kinase Signaling System | 1 | 2012 | 274 | 0.370 |
Why?
| | Jurkat Cells | 3 | 2022 | 130 | 0.370 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2012 | 967 | 0.340 |
Why?
| | Vesicular Transport Proteins | 3 | 2020 | 83 | 0.330 |
Why?
| | Endosomes | 4 | 2019 | 125 | 0.320 |
Why?
| | Fibroblasts | 1 | 2012 | 838 | 0.300 |
Why?
| | Protein Transport | 4 | 2018 | 400 | 0.290 |
Why?
| | Actin Cytoskeleton | 2 | 2020 | 93 | 0.280 |
Why?
| | Dendritic Cells | 2 | 2021 | 438 | 0.250 |
Why?
| | Lysosomes | 4 | 2020 | 125 | 0.230 |
Why?
| | Immunological Synapses | 2 | 2015 | 18 | 0.210 |
Why?
| | Cytokines | 2 | 2022 | 1858 | 0.210 |
Why?
| | Neoplasms, Second Primary | 1 | 2023 | 91 | 0.200 |
Why?
| | Burkholderia cenocepacia | 1 | 2020 | 4 | 0.180 |
Why?
| | Radiation Tolerance | 1 | 2021 | 92 | 0.180 |
Why?
| | Phagosomes | 1 | 2020 | 40 | 0.180 |
Why?
| | Actins | 1 | 2022 | 384 | 0.180 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 54 | 0.180 |
Why?
| | Neoplasm Proteins | 2 | 2021 | 388 | 0.180 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 62 | 0.170 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 145 | 0.170 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 118 | 0.170 |
Why?
| | HeLa Cells | 3 | 2016 | 567 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 55 | 0.170 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 153 | 0.160 |
Why?
| | Immunity | 1 | 2019 | 125 | 0.160 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2021 | 638 | 0.160 |
Why?
| | CDC2 Protein Kinase | 1 | 2018 | 25 | 0.160 |
Why?
| | Protein Binding | 4 | 2018 | 1918 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2018 | 60 | 0.160 |
Why?
| | Phenotype | 2 | 2022 | 2859 | 0.150 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.140 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 40 | 0.140 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2017 | 57 | 0.140 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 57 | 0.140 |
Why?
| | Immunotherapy | 1 | 2021 | 481 | 0.140 |
Why?
| | Neutrophils | 1 | 2022 | 1171 | 0.140 |
Why?
| | MicroRNAs | 1 | 2023 | 610 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 425 | 0.140 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 447 | 0.140 |
Why?
| | GTPase-Activating Proteins | 1 | 2016 | 72 | 0.140 |
Why?
| | RNA Stability | 1 | 2017 | 93 | 0.140 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 633 | 0.140 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 312 | 0.140 |
Why?
| | rab GTP-Binding Proteins | 1 | 2016 | 63 | 0.130 |
Why?
| | Up-Regulation | 1 | 2019 | 824 | 0.130 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2015 | 34 | 0.130 |
Why?
| | Amino Acid Sequence | 2 | 2019 | 2003 | 0.130 |
Why?
| | RNA, Messenger | 2 | 2019 | 2581 | 0.120 |
Why?
| | Proteolysis | 1 | 2015 | 145 | 0.120 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 83 | 0.120 |
Why?
| | Endocytosis | 1 | 2015 | 152 | 0.120 |
Why?
| | Sequence Alignment | 1 | 2015 | 328 | 0.120 |
Why?
| | Mice, Transgenic | 3 | 2019 | 1971 | 0.120 |
Why?
| | Mice | 8 | 2021 | 15085 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2015 | 136 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 156 | 0.110 |
Why?
| | Cation Transport Proteins | 1 | 2014 | 123 | 0.110 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2014 | 129 | 0.110 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2012 | 8 | 0.110 |
Why?
| | Phosphorylation | 2 | 2018 | 1562 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1045 | 0.110 |
Why?
| | Humans | 12 | 2023 | 115859 | 0.100 |
Why?
| | Signal Transduction | 4 | 2021 | 4527 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 145 | 0.100 |
Why?
| | Proteins | 2 | 2014 | 920 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 377 | 0.100 |
Why?
| | Flow Cytometry | 1 | 2015 | 1060 | 0.100 |
Why?
| | Cells, Cultured | 1 | 2019 | 3914 | 0.100 |
Why?
| | Cell Membrane | 1 | 2015 | 683 | 0.100 |
Why?
| | NF-kappa B | 1 | 2014 | 639 | 0.090 |
Why?
| | Animals | 9 | 2021 | 32158 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2021 | 2608 | 0.090 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2796 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2010 | 12 | 0.090 |
Why?
| | Clonal Anergy | 1 | 2010 | 53 | 0.090 |
Why?
| | Pyrimidines | 1 | 2012 | 376 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4779 | 0.080 |
Why?
| | Cell Line | 1 | 2015 | 2657 | 0.080 |
Why?
| | Cell Communication | 1 | 2010 | 280 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2014 | 721 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2021 | 2749 | 0.070 |
Why?
| | Cytoplasm | 2 | 2014 | 255 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2016 | 603 | 0.060 |
Why?
| | CTLA-4 Antigen | 1 | 2023 | 78 | 0.050 |
Why?
| | Gelatinases | 1 | 2022 | 6 | 0.050 |
Why?
| | Australia | 1 | 2023 | 206 | 0.050 |
Why?
| | Cytoplasmic Granules | 1 | 2022 | 82 | 0.050 |
Why?
| | Exocytosis | 1 | 2022 | 89 | 0.050 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 17 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 66 | 0.050 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2021 | 39 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2021 | 115 | 0.050 |
Why?
| | Models, Biological | 2 | 2018 | 1647 | 0.050 |
Why?
| | Actin-Related Protein 2-3 Complex | 1 | 2020 | 8 | 0.050 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 41 | 0.040 |
Why?
| | Tumor Burden | 1 | 2021 | 261 | 0.040 |
Why?
| | Cross Reactions | 1 | 2019 | 117 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2020 | 103 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2019 | 40 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 272 | 0.040 |
Why?
| | Female | 3 | 2020 | 60070 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 370 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 1169 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 139 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 424 | 0.040 |
Why?
| | Heterografts | 1 | 2018 | 119 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1127 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2021 | 369 | 0.040 |
Why?
| | Benzylamines | 1 | 2017 | 39 | 0.040 |
Why?
| | Sezary Syndrome | 1 | 2017 | 43 | 0.040 |
Why?
| | Heterocyclic Compounds | 1 | 2017 | 20 | 0.040 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 78 | 0.040 |
Why?
| | Male | 2 | 2020 | 56103 | 0.040 |
Why?
| | Survival Analysis | 1 | 2019 | 1218 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 688 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2017 | 341 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 3344 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2016 | 409 | 0.030 |
Why?
| | Phosphate-Binding Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| | Copper-transporting ATPases | 1 | 2014 | 5 | 0.030 |
Why?
| | Nuclear Localization Signals | 1 | 2014 | 14 | 0.030 |
Why?
| | Neoplastic Stem Cells | 1 | 2018 | 330 | 0.030 |
Why?
| | Influenza Vaccines | 1 | 2019 | 498 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2014 | 18 | 0.030 |
Why?
| | Ubiquitination | 1 | 2014 | 86 | 0.030 |
Why?
| | Copper | 1 | 2014 | 101 | 0.030 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 50 | 0.030 |
Why?
| | Deoxycytidine | 1 | 2014 | 140 | 0.030 |
Why?
| | Macrophages | 1 | 2020 | 1282 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 514 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1758 | 0.030 |
Why?
| | Inflammation | 1 | 2022 | 2502 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 796 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1143 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1550 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2014 | 554 | 0.020 |
Why?
| | Vaccination | 1 | 2019 | 1209 | 0.020 |
Why?
| | Chromatin | 1 | 2014 | 428 | 0.020 |
Why?
| | Homeostasis | 1 | 2014 | 577 | 0.020 |
Why?
| | Cell Movement | 1 | 2014 | 867 | 0.020 |
Why?
| | Base Sequence | 1 | 2014 | 2121 | 0.020 |
Why?
| | Aging | 1 | 2019 | 1635 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2010 | 152 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 204 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2018 | 3587 | 0.020 |
Why?
| | Mutation | 1 | 2014 | 3371 | 0.010 |
Why?
|
|
Osborne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|